Cardiovascular risk factor modification among high-risk patients: Do pharmacists play a role?

about

Cardiovascular risk factor modification among high-risk patients: Do pharmacists play a role?

Item

http://www.wikidata.org/entity/Q42150685

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Cardiovascular risk factor mod ...... s: Do pharmacists play a role?

@en

Cardiovascular risk factor mod ...... s: Do pharmacists play a role?

@nl

type

Item

label

Cardiovascular risk factor mod ...... s: Do pharmacists play a role?

@en

Cardiovascular risk factor mod ...... s: Do pharmacists play a role?

@nl

prefLabel

Cardiovascular risk factor mod ...... s: Do pharmacists play a role?

@en

Cardiovascular risk factor mod ...... s: Do pharmacists play a role?

@nl

P1476

Cardiovascular risk factor mod ...... s: Do pharmacists play a role?

@en

P2093

Jeffrey Chow

http://www.w3.org/2001/XMLSchema#string

Tammy J Bungard

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Secondary prevention of cardiovascular disease: a randomised trial of training in information management, evidence-based medicine, both or neither: the PIER trial.

Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS)

Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials.

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.

Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.

Hypertension treatment and control rates: chart review in an academic family medicine clinic.

Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.

The impact of prevention on reducing the burden of cardiovascular disease.

P304

257-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1715163513499125

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24093036

http://www.w3.org/2001/XMLSchema#string

P932

3785190

http://www.w3.org/2001/XMLSchema#string